AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aura Biosciences, Inc. Director's Dealing 2021

Oct 28, 2021

33080_dirs_2021-10-28_84fa5f5d-b77d-4791-a0f7-a120996d6140.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Aura Biosciences, Inc. (AURA)
CIK: 0001501796
Period of Report: 2021-10-28

Reporting Person: Mattessich Antony C. (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$9.59	2031-09-22	Common Stock (53649)		Direct

Footnotes

F1: The shares underlying this option vest in 48 monthly installments, equal to 2.0833% of the shares, over the 48 months following September 22, 2021.